1. Home
  2. IDYA vs VC Comparison

IDYA vs VC Comparison

Compare IDYA & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$31.70

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$100.28

Market Cap

2.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
VC
Founded
2015
2000
Country
United States
United States
Employees
N/A
10000
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
IDYA
VC
Price
$31.70
$100.28
Analyst Decision
Strong Buy
Buy
Analyst Count
16
14
Target Price
$52.86
$120.75
AVG Volume (30 Days)
1.5M
468.9K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
1.48%
EPS Growth
61.90
N/A
EPS
N/A
7.28
Revenue
$218,710,000.00
$3,768,000,000.00
Revenue This Year
N/A
$2.39
Revenue Next Year
$201.05
$5.21
P/E Ratio
N/A
$13.92
Revenue Growth
3024.43
N/A
52 Week Low
$16.82
$75.11
52 Week High
$39.28
$128.32

Technical Indicators

Market Signals
Indicator
IDYA
VC
Relative Strength Index (RSI) 46.97 64.48
Support Level $29.51 $96.66
Resistance Level $34.76 $106.35
Average True Range (ATR) 2.02 3.15
MACD 0.09 1.08
Stochastic Oscillator 19.44 77.67

Price Performance

Historical Comparison
IDYA
VC

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

Share on Social Networks: